Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients

References

• HouZLiGBaiSHigh dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-upJ Cancer Res Clin Oncol201514161063107125173623
   PubMed Web of Science ®Google Scholar
• Schmidt-HansenMHoskinPKirkbridePHaslerEBromhamNHormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analysesClin Oncol (R Coll Radiol)20142610e21e4625059922
   PubMed Web of Science ®Google Scholar
• WidmarkAKleppOSolbergAEndocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trialLancet200937330130819091394
   PubMed Web of Science ®Google Scholar
• DaneshmandMQuekLSteinJPrognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term resultsJ Urol200417262252225515538242
   PubMedGoogle Scholar
• DearnaleyDPJovicGSyndikusIEscalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomized controlled trialLancet Oncol201415446447324581940
   PubMed Web of Science ®Google Scholar
• CreakAHallEHorwichARandomized pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upBr J Cancer2013109365165723880826
   PubMed Web of Science ®Google Scholar
• SchiavinaRBertacciniAFranceschelliAThe impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patientsAnticancer Res20103062297230220651383
   PubMedGoogle Scholar
• MorikawaLRoachMPelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directionsInt J Radiat Oncol201180616
   PubMed Web of Science ®Google Scholar
• RoachMDeSilvioMValicentiRWhole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the radiation therapy oncology group 9413 trialInt J Radiat Oncol Biol Phys200666364765317011443
   PubMedGoogle Scholar
• PommierPChabaudSLagrangeJIs there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01J Clin Oncol200725345366537318048817
   PubMed Web of Science ®Google Scholar
• RoachMThe use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerJ Urol1993150192319247693984
   PubMedGoogle Scholar
• MurenLWasbøEHelleSIntensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiencesInt J Radiat Oncol Biol Phys20087141034104118249502
   PubMed Web of Science ®Google Scholar
• GoenkaAMagsanocJMPeiXImproved toxicity profile following high-dose post-prostatectomy salvage radiation therapy with intensity-modulated radiation therapyEur Urol20116061142114821855208
   PubMed Web of Science ®Google Scholar
• RiouOFenogliettoPLalibertéBThree years of salvage IMRT for prostate cancer: results of the Montpellier Cancer CenterISRN Urol2012391705
   Google Scholar
• FogartyGBNgDLiuGHayduLEBhandariNVolumetric modulated arc therapy is superior to conventional intensity-modulated radiotherapy – a comparison among prostate cancer patients treated in an Australian centreRadiat Oncol20116110821892944
   PubMedGoogle Scholar
• LawtonCAFMichalskiJEl-NaqaIRTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancerInt J Radiat Oncol Biol Phys20097438338718947938
   PubMed Web of Science ®Google Scholar
• JonesCUHuntDMcGowanDGRadiotherapy and short-term androgen deprivation for localized prostate cancerN Engl J Med2011365210711821751904
   PubMed Web of Science ®Google Scholar
• HouWHHuangCYWangCCImpact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiationAsian J Androl20161816
   Google Scholar
• ValicentiRKBaeKMichalskiJDoes hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of radiation therapy oncology group 94–06Int J Radiat Oncol Biol Phys2011791323132921414514
   PubMedGoogle Scholar
• FengFYBlasKOlsonKRetrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancerInt J Radiat Oncol Biol Phys201386647123462420
   PubMedGoogle Scholar
• ZapateroAGuerreroAMaldonadoXHigh-dose radiotherapy with short-term or long-term androgen deprivation in localized prostate cancer (DART01/05 GICOR): a randomized, controlled, phase 3 trialLancet Oncol20151632032725702876
   PubMed Web of Science ®Google Scholar
• StoyanovaRPahlajaniNHEglestonBLThe impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomogramsCancer201311951080108823096533
   PubMed Web of Science ®Google Scholar
• RoachMDose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?Strahlenther Onkol20071832262818167004
   PubMedGoogle Scholar
• ShakespeareTPEffect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologistsRadiat Oncol201510123323926582424
   PubMed Web of Science ®Google Scholar
• ShakespeareTPWilcoxSAherneNCan we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?Onco Targets Ther201692819282327274277
   PubMed Web of Science ®Google Scholar
• MorrisWTyldesleySRoddaSAndrogen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high-risk and intermediate-risk prostate cancerInt J Radiat Oncol Biol Phys201798227528528262473
   PubMed Web of Science ®Google Scholar
• DenhamJSteiglerALambDSShort-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman radiation oncology group 96.01 randomized controlled trialLancet Oncol200561184185016257791
   PubMed Web of Science ®Google Scholar
• ZapateroAGarcía-VicenteFSevillanoDIs hormone therapy a protective factor for late hematuria after high-dose radiotherapy in prostate cancer?Urology20087251130113418400265
   PubMed Web of Science ®Google Scholar
• SieberMRüfferUJostingADiehlVTreatment of Hodgkin’s disease: current strategies of the German Hodgkin’s lymphoma study groupAnn Oncol199910Suppl 6232910676550
   PubMed Web of Science ®Google Scholar